---
figid: PMC6167999__ijn-13-5909Fig14
figlink: /pmc/articles/PMC6167999/figure/f14-ijn-13-5909/
number: Figure 14
caption: Schematic representation of nanoparticulate TiO2-mediated inhibition of testosterone
  production via the ERK1/2–PKA–PKC signaling pathway. Taken together, data from the
  current study suggest that nano-TiO2 enters the cytoplasm and nuclei of LCs, causing
  structural damage and decreased cell activity and testosterone generation or secretion.
  Furthermore, suppression of testosterone production in LCs by nano-TiO2 may be associated
  with dysfunction of ERK1/2–PKA–PKC signaling pathways, with downregulation of StAR,
  P450scc, 3βHSD, SR-BI, PKA, PKC, and pERK/1/2 and upregulation of DAX1. The complex
  dynamic pathway of nano-TiO2-mediated inhibition of testosterone synthesis or secretion
  in LCs requires further investigation.
pmcid: PMC6167999
papertitle: Suppression of testosterone production by nanoparticulate TiO2 is associated
  with ERK1/2–PKA–PKC signaling pathways in rat primary cultured Leydig cells.
reftext: Lingjuan Li, et al. Int J Nanomedicine. 2018;13:5909-5924.
pmc_ranked_result_index: '11387'
pathway_score: 0.9511974
filename: ijn-13-5909Fig14.jpg
figtitle: Nanoparticulate TiO2-mediated inhibition of testosterone production via
  the ERK1/2–PKA–PKC signaling pathway
year: '2018'
organisms: Homo sapiens
ndex: ed75a2e9-def3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6167999__ijn-13-5909Fig14.html
  '@type': Dataset
  description: Schematic representation of nanoparticulate TiO2-mediated inhibition
    of testosterone production via the ERK1/2–PKA–PKC signaling pathway. Taken together,
    data from the current study suggest that nano-TiO2 enters the cytoplasm and nuclei
    of LCs, causing structural damage and decreased cell activity and testosterone
    generation or secretion. Furthermore, suppression of testosterone production in
    LCs by nano-TiO2 may be associated with dysfunction of ERK1/2–PKA–PKC signaling
    pathways, with downregulation of StAR, P450scc, 3βHSD, SR-BI, PKA, PKC, and pERK/1/2
    and upregulation of DAX1. The complex dynamic pathway of nano-TiO2-mediated inhibition
    of testosterone synthesis or secretion in LCs requires further investigation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKACG
  - NR0B1
  - PRKCZ
  - CYP11A1
  - PRKACB
  - PRKAR2B
  - SCARB1
  - STAR
  - PRKACA
  - PRKD3
  - MAPK3
  - PRKAR1A
  - PRKCA
  - PRKCQ
  - MAPK1
  - PRKCB
  - PRKCI
  - PRKAR2A
  - PRKCH
  - PRKAR1B
  - PRKCE
  - PRKCG
  - PRKCD
  - AMP
  - cholesterin
  - pregnenolone
  - testosterone
genes:
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: DAX-1
  symbol: DAX1
  source: hgnc_alias_symbol
  hgnc_symbol: NR0B1
  entrez: '190'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: P450scc
  symbol: P450SCC
  source: hgnc_alias_symbol
  hgnc_symbol: CYP11A1
  entrez: '1583'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: SR-BI
  symbol: SR-BI
  source: hgnc_alias_symbol
  hgnc_symbol: SCARB1
  entrez: '949'
- word: STAR
  symbol: STAR
  source: hgnc_symbol
  hgnc_symbol: STAR
  entrez: '6770'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: P-ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: P-ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
chemicals:
- word: AMP
  source: MESH
  identifier: D000249
- word: cholesterin
  source: ''
  identifier: ''
- word: pregnenolone
  source: MESH
  identifier: D011284
- word: testosterone
  source: MESH
  identifier: D013739
diseases: []
---
